1 | largest | 2,872 |
2 | strongest | 1,861 |
3 | earliest | 612 |
4 | longest | 570 |
5 | smallest | 512 |
6 | shortest | 323 |
7 | fastest | 208 |
8 | biggest | 178 |
9 | poorest | 168 |
10 | fewest | 108 |
11 | weakest | 74 |
12 | deepest | 66 |
13 | widest | 63 |
14 | broadest | 39 |
15 | clearest | 34 |
16 | richest | 28 |
17 | best-known | 24 |
18 | narrowest | 24 |
19 | leidenfrost | 20 |
20 | thickest | 16 |
21 | pragmatic-explanatory | 14 |
22 | staged-air | 14 |
23 | fastest-growing | 12 |
24 | northernmost | 9 |
25 | tallest | 7 |
26 | bcll | 6 |
27 | easternmost | 6 |
28 | eurodiab | 6 |
29 | nordic-vii | 6 |
30 | amsterdam-nijmegen | 5 |
31 | mid-ventilation | 5 |
32 | patients´ | 5 |
33 | tightest | 5 |
34 | axotomy-induced | 4 |
35 | cleanest | 4 |
36 | overture | 4 |
37 | sahel | 4 |
38 | sharpest | 4 |
39 | 105-d | 3 |
40 | alum-prp | 3 |
41 | apomorphine-induced | 3 |
42 | baltimore-washington | 3 |
43 | blakesley | 3 |
44 | cp43-less | 3 |
45 | genomelab | 3 |
46 | hemianopic | 3 |
47 | metabolin | 3 |
48 | nha-burden | 3 |
49 | westernmost | 3 |
50 | 'cv | 2 |
51 | -50t/c | 2 |
52 | 30-gene | 2 |
53 | ansung-ansan | 2 |
54 | assay-independent | 2 |
55 | aza-induced | 2 |
56 | cardiorenovascular | 2 |
57 | clinicohistopathological | 2 |
58 | ctl-induced | 2 |
59 | danubian | 2 |
60 | differents | 2 |
61 | esc/2008 | 2 |
62 | ethekwini | 2 |
63 | insertion-length | 2 |
64 | interest-activity | 2 |
65 | lysr | 2 |
66 | mesocercarial | 2 |
67 | metabolite/drug | 2 |
68 | motor-cargo | 2 |
69 | northern-most | 2 |
70 | obesity-a | 2 |
71 | preslo | 2 |
72 | prodrige | 2 |
73 | psi-a/b | 2 |
74 | rfa-induced | 2 |
75 | ritonavir-related | 2 |
76 | s0325 | 2 |
77 | s8a | 2 |
78 | seto | 2 |
79 | thermal-optic | 2 |
80 | time-coincident | 2 |
81 | triple-plane | 2 |
82 | well-explored | 2 |
83 | 'wald | 1 |
84 | /ba/-/da/ | 1 |
85 | 1-benzoyl-3-n-pentylindole | 1 |
86 | 1-phenyl-1,3-butadiene | 1 |
87 | 14-3-3ζ/ε | 1 |
88 | 17β-aminoestrogens | 1 |
89 | 25-74-year-old | 1 |
90 | 3-lactobacillus | 1 |
91 | 40°-angled | 1 |
92 | 444,088 | 1 |
93 | 480-ml | 1 |
94 | absorption/transport | 1 |
95 | amorphous-crystalline | 1 |
96 | anti-ibs | 1 |
97 | asthma-severity | 1 |
98 | cardio-reno-vascular | 1 |
99 | cardol-cardanol | 1 |
100 | caribe-hf | 1 |
101 | cell-propagated | 1 |
102 | choquet | 1 |
103 | diasteromeric | 1 |
104 | distractor-elicited | 1 |
105 | dodalab | 1 |
106 | dwass-steele-critchow-fligner | 1 |
107 | dye-sensitive | 1 |
108 | early/fresh | 1 |
109 | early/preclinical | 1 |
110 | erlang | 1 |
111 | esculentoside | 1 |
112 | estimates.the | 1 |
113 | eusociality | 1 |
114 | f2-f3 | 1 |
115 | failure/success | 1 |
116 | fpd-facilitated | 1 |
117 | freshwater-marine | 1 |
118 | gercor/giscad | 1 |
119 | glucose-casein | 1 |
120 | greathy | 1 |
121 | gut-dwelling | 1 |
122 | havyaka | 1 |
123 | health-illness | 1 |
124 | herbometallic | 1 |
125 | ja-inducing | 1 |
126 | lacquer-voc | 1 |
127 | less-cytotoxic | 1 |
128 | liver-bile | 1 |
129 | long-term.more | 1 |
130 | lower/middle | 1 |
131 | lung-thorax | 1 |
132 | mci-ad | 1 |
133 | mid-developmental | 1 |
134 | middle-to-late | 1 |
135 | mrc/wits | 1 |
136 | mrgprd+/non-peptidergic | 1 |
137 | noncompleter | 1 |
138 | normal-binomial | 1 |
139 | pae-derived | 1 |
140 | pb1/pa | 1 |
141 | penta-antigen | 1 |
142 | pipoz/pnipam | 1 |
143 | post-gastrula | 1 |
144 | pre-contemplation/contemplation/preparation | 1 |
145 | pre-translocation | 1 |
146 | precancer/cancer | 1 |
147 | precellular | 1 |
148 | precursor/suppressor-effector | 1 |
149 | preoperatively-depressed | 1 |
150 | pretsent | 1 |
151 | procedures.a | 1 |
152 | ps/was | 1 |
153 | psycho-behavioural | 1 |
154 | qanuippitaa | 1 |
155 | re5 | 1 |
156 | research-to-practice-to-community | 1 |
157 | saharawi | 1 |
158 | shca-supported | 1 |
159 | sivers | 1 |
160 | step-down-type | 1 |
161 | suleiman | 1 |
162 | ta/tpa | 1 |
163 | tokyo-kanagawa | 1 |
164 | trongest | 1 |
165 | unprotected-sex | 1 |
166 | urea/isourea | 1 |
167 | vδ1 | 1 |
168 | within-stable-subject | 1 |
169 | wrist-palm | 1 |
170 | γ-gauche | 1 |
1 | 'cv | 2 |
2 | 'wald | 1 |
3 | -50t/c | 2 |
4 | /ba/-/da/ | 1 |
5 | 1-benzoyl-3-n-pentylindole | 1 |
6 | 1-phenyl-1,3-butadiene | 1 |
7 | 105-d | 3 |
8 | 14-3-3ζ/ε | 1 |
9 | 17β-aminoestrogens | 1 |
10 | 25-74-year-old | 1 |
11 | 3-lactobacillus | 1 |
12 | 30-gene | 2 |
13 | 40°-angled | 1 |
14 | 444,088 | 1 |
15 | 480-ml | 1 |
16 | absorption/transport | 1 |
17 | alum-prp | 3 |
18 | amorphous-crystalline | 1 |
19 | amsterdam-nijmegen | 5 |
20 | ansung-ansan | 2 |
21 | anti-ibs | 1 |
22 | apomorphine-induced | 3 |
23 | assay-independent | 2 |
24 | asthma-severity | 1 |
25 | axotomy-induced | 4 |
26 | aza-induced | 2 |
27 | baltimore-washington | 3 |
28 | bcll | 6 |
29 | best-known | 24 |
30 | biggest | 178 |
31 | blakesley | 3 |
32 | broadest | 39 |
33 | cardio-reno-vascular | 1 |
34 | cardiorenovascular | 2 |
35 | cardol-cardanol | 1 |
36 | caribe-hf | 1 |
37 | cell-propagated | 1 |
38 | choquet | 1 |
39 | cleanest | 4 |
40 | clearest | 34 |
41 | clinicohistopathological | 2 |
42 | cp43-less | 3 |
43 | ctl-induced | 2 |
44 | danubian | 2 |
45 | deepest | 66 |
46 | diasteromeric | 1 |
47 | differents | 2 |
48 | distractor-elicited | 1 |
49 | dodalab | 1 |
50 | dwass-steele-critchow-fligner | 1 |
51 | dye-sensitive | 1 |
52 | earliest | 612 |
53 | early/fresh | 1 |
54 | early/preclinical | 1 |
55 | easternmost | 6 |
56 | erlang | 1 |
57 | esc/2008 | 2 |
58 | esculentoside | 1 |
59 | estimates.the | 1 |
60 | ethekwini | 2 |
61 | eurodiab | 6 |
62 | eusociality | 1 |
63 | f2-f3 | 1 |
64 | failure/success | 1 |
65 | fastest | 208 |
66 | fastest-growing | 12 |
67 | fewest | 108 |
68 | fpd-facilitated | 1 |
69 | freshwater-marine | 1 |
70 | genomelab | 3 |
71 | gercor/giscad | 1 |
72 | glucose-casein | 1 |
73 | greathy | 1 |
74 | gut-dwelling | 1 |
75 | havyaka | 1 |
76 | health-illness | 1 |
77 | hemianopic | 3 |
78 | herbometallic | 1 |
79 | insertion-length | 2 |
80 | interest-activity | 2 |
81 | ja-inducing | 1 |
82 | lacquer-voc | 1 |
83 | largest | 2,872 |
84 | leidenfrost | 20 |
85 | less-cytotoxic | 1 |
86 | liver-bile | 1 |
87 | long-term.more | 1 |
88 | longest | 570 |
89 | lower/middle | 1 |
90 | lung-thorax | 1 |
91 | lysr | 2 |
92 | mci-ad | 1 |
93 | mesocercarial | 2 |
94 | metabolin | 3 |
95 | metabolite/drug | 2 |
96 | mid-developmental | 1 |
97 | mid-ventilation | 5 |
98 | middle-to-late | 1 |
99 | motor-cargo | 2 |
100 | mrc/wits | 1 |
101 | mrgprd+/non-peptidergic | 1 |
102 | narrowest | 24 |
103 | nha-burden | 3 |
104 | noncompleter | 1 |
105 | nordic-vii | 6 |
106 | normal-binomial | 1 |
107 | northern-most | 2 |
108 | northernmost | 9 |
109 | obesity-a | 2 |
110 | overture | 4 |
111 | pae-derived | 1 |
112 | patients´ | 5 |
113 | pb1/pa | 1 |
114 | penta-antigen | 1 |
115 | pipoz/pnipam | 1 |
116 | poorest | 168 |
117 | post-gastrula | 1 |
118 | pragmatic-explanatory | 14 |
119 | pre-contemplation/contemplation/preparation | 1 |
120 | pre-translocation | 1 |
121 | precancer/cancer | 1 |
122 | precellular | 1 |
123 | precursor/suppressor-effector | 1 |
124 | preoperatively-depressed | 1 |
125 | preslo | 2 |
126 | pretsent | 1 |
127 | procedures.a | 1 |
128 | prodrige | 2 |
129 | ps/was | 1 |
130 | psi-a/b | 2 |
131 | psycho-behavioural | 1 |
132 | qanuippitaa | 1 |
133 | re5 | 1 |
134 | research-to-practice-to-community | 1 |
135 | rfa-induced | 2 |
136 | richest | 28 |
137 | ritonavir-related | 2 |
138 | s0325 | 2 |
139 | s8a | 2 |
140 | saharawi | 1 |
141 | sahel | 4 |
142 | seto | 2 |
143 | sharpest | 4 |
144 | shca-supported | 1 |
145 | shortest | 323 |
146 | sivers | 1 |
147 | smallest | 512 |
148 | staged-air | 14 |
149 | step-down-type | 1 |
150 | strongest | 1,861 |
151 | suleiman | 1 |
152 | ta/tpa | 1 |
153 | tallest | 7 |
154 | thermal-optic | 2 |
155 | thickest | 16 |
156 | tightest | 5 |
157 | time-coincident | 2 |
158 | tokyo-kanagawa | 1 |
159 | triple-plane | 2 |
160 | trongest | 1 |
161 | unprotected-sex | 1 |
162 | urea/isourea | 1 |
163 | vδ1 | 1 |
164 | weakest | 74 |
165 | well-explored | 2 |
166 | westernmost | 3 |
167 | widest | 63 |
168 | within-stable-subject | 1 |
169 | wrist-palm | 1 |
170 | γ-gauche | 1 |
1 | /ba/-/da/ | 1 |
2 | vδ1 | 1 |
3 | f2-f3 | 1 |
4 | s0325 | 2 |
5 | re5 | 1 |
6 | esc/2008 | 2 |
7 | 444,088 | 1 |
8 | obesity-a | 2 |
9 | procedures.a | 1 |
10 | s8a | 2 |
11 | qanuippitaa | 1 |
12 | urea/isourea | 1 |
13 | havyaka | 1 |
14 | post-gastrula | 1 |
15 | pb1/pa | 1 |
16 | ta/tpa | 1 |
17 | tokyo-kanagawa | 1 |
18 | psi-a/b | 2 |
19 | eurodiab | 6 |
20 | dodalab | 1 |
21 | genomelab | 3 |
22 | -50t/c | 2 |
23 | mrgprd+/non-peptidergic | 1 |
24 | herbometallic | 1 |
25 | hemianopic | 3 |
26 | diasteromeric | 1 |
27 | thermal-optic | 2 |
28 | less-cytotoxic | 1 |
29 | lacquer-voc | 1 |
30 | 105-d | 3 |
31 | mci-ad | 1 |
32 | gercor/giscad | 1 |
33 | rfa-induced | 2 |
34 | aza-induced | 2 |
35 | apomorphine-induced | 3 |
36 | ctl-induced | 2 |
37 | axotomy-induced | 4 |
38 | 40°-angled | 1 |
39 | well-explored | 2 |
40 | preoperatively-depressed | 1 |
41 | cell-propagated | 1 |
42 | ritonavir-related | 2 |
43 | fpd-facilitated | 1 |
44 | distractor-elicited | 1 |
45 | shca-supported | 1 |
46 | pae-derived | 1 |
47 | 'wald | 1 |
48 | 25-74-year-old | 1 |
49 | esculentoside | 1 |
50 | prodrige | 2 |
51 | γ-gauche | 1 |
52 | estimates.the | 1 |
53 | lower/middle | 1 |
54 | liver-bile | 1 |
55 | 1-benzoyl-3-n-pentylindole | 1 |
56 | triple-plane | 2 |
57 | 30-gene | 2 |
58 | 1-phenyl-1,3-butadiene | 1 |
59 | amorphous-crystalline | 1 |
60 | freshwater-marine | 1 |
61 | step-down-type | 1 |
62 | long-term.more | 1 |
63 | overture | 4 |
64 | middle-to-late | 1 |
65 | dye-sensitive | 1 |
66 | caribe-hf | 1 |
67 | erlang | 1 |
68 | ja-inducing | 1 |
69 | gut-dwelling | 1 |
70 | fastest-growing | 12 |
71 | metabolite/drug | 2 |
72 | early/fresh | 1 |
73 | insertion-length | 2 |
74 | nordic-vii | 6 |
75 | ethekwini | 2 |
76 | saharawi | 1 |
77 | clinicohistopathological | 2 |
78 | early/preclinical | 1 |
79 | normal-binomial | 1 |
80 | mesocercarial | 2 |
81 | psycho-behavioural | 1 |
82 | mid-developmental | 1 |
83 | sahel | 4 |
84 | bcll | 6 |
85 | 480-ml | 1 |
86 | cardol-cardanol | 1 |
87 | pipoz/pnipam | 1 |
88 | wrist-palm | 1 |
89 | danubian | 2 |
90 | suleiman | 1 |
91 | ansung-ansan | 2 |
92 | nha-burden | 3 |
93 | amsterdam-nijmegen | 5 |
94 | penta-antigen | 1 |
95 | glucose-casein | 1 |
96 | metabolin | 3 |
97 | pre-translocation | 1 |
98 | mid-ventilation | 5 |
99 | pre-contemplation/contemplation/preparation | 1 |
100 | baltimore-washington | 3 |
101 | best-known | 24 |
102 | motor-cargo | 2 |
103 | preslo | 2 |
104 | seto | 2 |
105 | alum-prp | 3 |
106 | cardio-reno-vascular | 1 |
107 | cardiorenovascular | 2 |
108 | precellular | 1 |
109 | precancer/cancer | 1 |
110 | dwass-steele-critchow-fligner | 1 |
111 | noncompleter | 1 |
112 | staged-air | 14 |
113 | precursor/suppressor-effector | 1 |
114 | lysr | 2 |
115 | ps/was | 1 |
116 | anti-ibs | 1 |
117 | 17β-aminoestrogens | 1 |
118 | sivers | 1 |
119 | failure/success | 1 |
120 | cp43-less | 3 |
121 | health-illness | 1 |
122 | mrc/wits | 1 |
123 | differents | 2 |
124 | 3-lactobacillus | 1 |
125 | within-stable-subject | 1 |
126 | choquet | 1 |
127 | time-coincident | 2 |
128 | assay-independent | 2 |
129 | pretsent | 1 |
130 | absorption/transport | 1 |
131 | broadest | 39 |
132 | widest | 63 |
133 | biggest | 178 |
134 | longest | 570 |
135 | trongest | 1 |
136 | strongest | 1,861 |
137 | largest | 2,872 |
138 | richest | 28 |
139 | earliest | 612 |
140 | weakest | 74 |
141 | thickest | 16 |
142 | smallest | 512 |
143 | tallest | 7 |
144 | cleanest | 4 |
145 | deepest | 66 |
146 | sharpest | 4 |
147 | clearest | 34 |
148 | poorest | 168 |
149 | tightest | 5 |
150 | shortest | 323 |
151 | fastest | 208 |
152 | fewest | 108 |
153 | narrowest | 24 |
154 | northern-most | 2 |
155 | northernmost | 9 |
156 | easternmost | 6 |
157 | westernmost | 3 |
158 | leidenfrost | 20 |
159 | 'cv | 2 |
160 | lung-thorax | 1 |
161 | unprotected-sex | 1 |
162 | blakesley | 3 |
163 | greathy | 1 |
164 | pragmatic-explanatory | 14 |
165 | eusociality | 1 |
166 | research-to-practice-to-community | 1 |
167 | asthma-severity | 1 |
168 | interest-activity | 2 |
169 | patients´ | 5 |
170 | 14-3-3ζ/ε | 1 |